Patent ID: 11878059
Assignee: UNIVERSITY OF ULSTER
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A

Claim 13:
14. A complex as claimed in claim 13, wherein said one or more additional chemotherapeutic agents are selected from the following: antifolates; 5-fluoropyrimidines; cytidine analogues; purine antimetabolites; alkylating agents; non-classical alkylating agents; platinum analogues; antitumour antibiotics; bioreductive drugs; anthracyclines; topoisomerase I inhibitors; topoisomease II inhibitors; antimicrotubule agents such as vinca alkaloids, taxols, and epothilones; antioestrogens; antiandrogens; aromatase inhibitors; antiangiogenic or hypoxia targeting drugs; antivascular agents; tyrosine kinase inhibitors; oncogene or signalling pathway targeting agents; agents targeting stress proteins; autophagy targeting agents; proteasome targeting agents; telomerase inhibitors; histone deacetylase inhibitors; DNA methyl transferase inhibitors; alkyl sulfonates; aziridines; ethylenimines and methylamelamines; nitrogen mustards; nitrosureas; purine analogues; pyrimidine analogues; androgens; anti-adrenals, and immune checkpoint inhibitors; and pharmaceutically acceptable salts, derivatives or analogues of any of these compounds or anti-metabolites.